CRISPR Therapeutics AG News
Cathie Wood Defends Strategy: Innovation 'Solves Problems'
'Innovation tends to gain traction during difficult times because it solves problems,' the prominent asset manager Cathie Wood says in a webinar.
Cathie Wood's Flagship Fund Keeps Falling
Ark Innovation ETF recently traded at $36.95, not far from its pandemic-low close of $34.69 on March 18, 2020.
This CRISPR Stock Plunged On Cell Therapy's Looming Question
A certain type of cell therapy is easier to manufacture, but may lead to worse long-term outcomes for patients.
bluebird bio (Finally) Nears Approval. What's Next?
The gene therapy pioneer may earn approval years after initially teasing investors. It may not be time to celebrate.
Cathie Wood Hints at New Fund With Private Investments
Asset manager Cathie Wood hinted that she'd start up a fund that would include private investments.
Roe Decision Forces Disney, Netflix to Take a Political Stand
Disney, JP Morgan Chase, and outgoing Meta COO Sheryl Sandberg are just a few speaking out against the ruling.
Netflix Lays Offs More Employees To Cut Costs
Netflix layoffs continue as the streaming giant executes a plan to cope with slow revenue growth.
These Five Things Could Help (or Hurt) Internet Stocks
Bank of America analysts outline some of the biggest issues facing Amazon, Alphabet, Meta and other internet-related stocks.
Disney Mobile Game Opens Up a New Universe
Familiar Disney characters populate an alternate reality in new interactive game.